Llwytho...

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report

A germline pathogenic variant in BRCA2 was secondarily found through genomic sequencing of uterine serous carcinoma. Clinical response to olaparib was observed in recurrent uterine serous carcinoma with a germline BRCA2 mutation. Here, we report, for the first time, a long-term clinical response to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Gynecol Oncol Rep
Prif Awduron: Inoue, Kayo, Tsubamoto, Hiroshi, Ueda, Tomoko, Tajima, Chihiro, Nakagomi, Nami
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7152717/
https://ncbi.nlm.nih.gov/pubmed/32300630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100563
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!